Targeting MAPK4 emerges as a promising therapy for prostate cancer
The battle against late-stage prostate cancer might have found a potential new strategy to combat this deadly disease. Research led by Baylor College of Medicine reveals in the Journal of Clinical Investigation that the enzyme ...
Feb 19, 2021
0
37